HBM Healthcare Investments

HBM Healthcare Investments is a Swiss investment company focused on the global healthcare market. They invest in both private and public healthcare companies, aiming for a well-balanced and diversified portfolio. Their investment strategy involves identifying companies with development potential, investing in early financing rounds, and expanding investments through follow-on rounds and IPOs. HBM emphasizes broad diversification across private and public companies, development phase, therapeutic area, geography, and company size. They focus on companies developing groundbreaking therapies with the potential to improve health and well-being globally. They look for opportunities to achieve attractive performance, with the past years showing strong NAV per share and share price performance with an average dividend yield of 3-5 percent per year. HBM's investment approach is rooted in the belief that the healthcare sector is attractive due to demographic trends, medical progress, rising prosperity, and unmet needs for new therapies. They prioritize investments in companies that are revenue-generating or have products in advanced stages of development. The firm's asset allocation includes significant investments in private companies and companies transitioning from private to public markets. In terms of sustainability, HBM aligns with ESG and SDG principles. By investing in healthcare companies, particularly those focused on R&D, they aim to support innovation that has a positive impact on society and limited environmental impact. HBM leverages the ESG/SDG Guidelines established by HBM Partners AG to guide their investment decisions. Their strategy naturally aligns with the goals of ESG and SDG, promoting the well-being of the environment and the population.

Healthcare, Biotechnology, Pharmaceuticals, Medical Technology, Diagnostics, Digital Health

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.